Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
Content provided by Hal Nesbitt and American Society of Nephrology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hal Nesbitt and American Society of Nephrology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
PLA2R Antibodies and Treatment Response
Manage episode 379270613 series 1521637
Content provided by Hal Nesbitt and American Society of Nephrology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hal Nesbitt and American Society of Nephrology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.
…
continue reading
206 episodes
PLA2R Antibodies and Treatment Response
Clinical Journal of the American Society of Nephrology (CJASN)
Manage episode 379270613 series 1521637
Content provided by Hal Nesbitt and American Society of Nephrology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hal Nesbitt and American Society of Nephrology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Drs. Daniel Cattran and Sean Barbour summarize the main results of their study, "Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy," on behalf of their colleagues.
…
continue reading
206 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.